4Hirsh J,Warkentin TE,Shaughnessy SG,et al.Heparin and low molecular weight heparin :mechanisms of action,pharmacokinetics, dosing, monitoring, efficacy, and safety [J].Chest, 2001,119( 1Suppl):64-74.
5Aronow WS.Management of peripheral arterial disease of lower extremities in elderly patients [J].J Gerontology, 2004,59(2):172.
6Devine C,MeCollum C.North West Femoro Popliteal Trial Participants.Heparin onded Dacron or polytetrafluorethylene for femoropopliteal bypass:five year results of a prospective randomized muhicenter clinical trial[J].J Vasc Surg,2004,40 (5):924-931.
